SCHEMBL3368757

SCHEMBL3368757

CN1CCN(CCCNCc2cc(-c3ccc4c(c3)OCO4)n(S(=O)(=O)c3cccc(Cl)c3)c2)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 11/20 0.44
MAPK1 P28482 2/20 0.40
TSHR P16473 2/20 0.40
ALDH1A1 P00352 2/20 0.40
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
GAA P10253 1/20 0.40
HPGD P15428 1/20 0.40
ALOX15 P16050 1/20 0.40
KMT2A Q03164 1/20 0.40
HSD17B10 Q99714 1/20 0.40
DPP7 Q9UHL4 1/20 0.38
TP53 P04637 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CHRM3 P20309 1/20 0.37
POLB P06746 1/20 0.37
ABL1 P00519 1/20 0.36
INSR P06213 1/20 0.36
NPM1 P06748 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3367906 0.74 GLRA3 (0.41) HTR6MAPK1TSHRALDH1A1KDM4E
SCHEMBL3368457 0.74 GLRA3 (0.42) HTR6MAPK1TSHRALDH1A1KDM4E
SCHEMBL3370448 0.73 MEN1 (0.48) TSHRALDH1A1KDM4EMEN1GAA
SCHEMBL4455226 0.69 CHEK2 (0.40) MAPK1TSHRALDH1A1KDM4EMEN1
SCHEMBL17520499 0.69 HTT (0.46) MAPK1TSHRALDH1A1KDM4EGAA
SCHEMBL3370190 0.69 GLRA3 (0.39) HTR6MAPK1TSHRALDH1A1KDM4E
SCHEMBL3371527 0.68 HTR6 (0.42) HTR6MEN1KMT2A
SCHEMBL1580310 0.67 HTR6 (0.42) HTR6ALDH1A1KDM4EMEN1KMT2A
SCHEMBL1580794 0.66 HTR6 (0.41) HTR6ALDH1A1MEN1KMT2A
Hydrochloric Acid SCHEMBL1156956 0.66 HTR6 (0.42) HTR6ALDH1A1KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1628957-B1 SULFOPYRROLES TAKEDA PHARMACEUTICAL (JP) 2010-09-29 EP disclosed
US-7612064-B2 Sulfopyrroles TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-11-03 US disclosed
US-20070060570-A1 Sulfopyrroles TALEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060570-A1 Sulfopyrroles TYK2, ARSA, SULT2A1 HTR6 1949/4885MAPK1 1610/4885TSHR 740/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.